FI973185A0 - Use of melatonin in the treatment of patients with drug dependence - Google Patents

Use of melatonin in the treatment of patients with drug dependence

Info

Publication number
FI973185A0
FI973185A0 FI973185A FI973185A FI973185A0 FI 973185 A0 FI973185 A0 FI 973185A0 FI 973185 A FI973185 A FI 973185A FI 973185 A FI973185 A FI 973185A FI 973185 A0 FI973185 A0 FI 973185A0
Authority
FI
Finland
Prior art keywords
melatonin
patients
treatment
drug dependence
dependence
Prior art date
Application number
FI973185A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI119586B (en
FI973185L (en
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of FI973185A0 publication Critical patent/FI973185A0/en
Publication of FI973185L publication Critical patent/FI973185L/en
Application granted granted Critical
Publication of FI119586B publication Critical patent/FI119586B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI973185A 1995-02-01 1997-07-31 Use of melatonin for the manufacture of a drug for the treatment of patients suffering from drug dependence FI119586B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US38153595 1995-02-01
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
EP95303853 1995-06-06
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction
IB9600082 1996-01-29

Publications (3)

Publication Number Publication Date
FI973185A0 true FI973185A0 (en) 1997-07-31
FI973185L FI973185L (en) 1997-09-30
FI119586B FI119586B (en) 2009-01-15

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973185A FI119586B (en) 1995-02-01 1997-07-31 Use of melatonin for the manufacture of a drug for the treatment of patients suffering from drug dependence

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227002B1 (en) 2000-01-05 2010-04-28 Neurim Pharma 1991 Use of melatonin in the manufacture of controlled release medicament for the prevention or treatment of symptoms of hypertension
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
PT2806863T (en) * 2012-01-26 2017-11-09 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
EP3767297A1 (en) 2012-12-18 2021-01-20 Vanda Pharmaceuticals Inc. Method of determining tau and thereby determining whether a patient has a free-running circadian rhythm
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
AU2016426598C1 (en) * 2016-10-31 2024-02-08 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0518468T3 (en) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatonin-containing compositions
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
NO973531D0 (en) 1997-07-31
NO312814B1 (en) 2002-07-08
CN1172431A (en) 1998-02-04
NO973531L (en) 1997-09-30
CZ240597A3 (en) 1998-01-14
SK103097A3 (en) 1998-01-14
LV11940A (en) 1998-01-20
DK176081B1 (en) 2006-04-18
AT408188B (en) 2001-09-25
DK89697A (en) 1997-07-30
JP4516159B2 (en) 2010-08-04
SI9620022A (en) 1998-10-31
IS1980B (en) 2005-01-14
EE9700166A (en) 1998-02-16
AU695366B2 (en) 1998-08-13
NZ298878A (en) 1999-05-28
MD1716B2 (en) 2001-08-31
PL183148B1 (en) 2002-05-31
CZ291349B6 (en) 2003-02-12
FI119586B (en) 2009-01-15
TR199700723T1 (en) 1998-02-21
BG62876B1 (en) 2000-10-31
LV11940B (en) 1998-05-20
LU90118B1 (en) 1997-11-13
CN1083263C (en) 2002-04-24
MX9705856A (en) 1998-07-31
AU4457496A (en) 1996-08-21
BR9607169A (en) 1997-11-11
TW483757B (en) 2002-04-21
ATA901396A (en) 2001-02-15
FI973185L (en) 1997-09-30
EE03384B1 (en) 2001-04-16
WO1996023496A1 (en) 1996-08-08
MD970254A (en) 1999-05-31
JPH10513177A (en) 1998-12-15
PL321630A1 (en) 1997-12-08
BG101803A (en) 1998-04-30
SK284521B6 (en) 2005-05-05
MD1716C2 (en) 2002-02-28
IS4532A (en) 1997-07-25

Similar Documents

Publication Publication Date Title
CY2007001I2 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
FI963696L (en) Gel for the treatment of skin diseases and skin disinfection
LV11615A (en) Amid with medical treatment
EE9800158A (en) Epinastine for use in the treatment of pain
FI953838L (en) Imidazopyridines and their use in the treatment of gastrointestinal diseases
LV10878A (en) Treatment of the skin with selected amphiphilic copolymers
FI963252A7 (en) Novel opioid peptides for the treatment of pain and their use
DE69310325D1 (en) Patient treatment device with mattress and treatment chamber
DK0668763T3 (en) Use of Phenserin in the manufacture of drugs for the treatment of cognitive disorders
NO975718L (en) Treatment of insulin resistance
FI973185A0 (en) Use of melatonin in the treatment of patients with drug dependence
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
FI941345A7 (en) Retinoids and their use in the treatment of skin diseases and leukemia
FI971527L (en) Use of indole derivatives for the treatment of various diseases
KR960702315A (en) Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage
FI974609A7 (en) New heterocyclic compounds for the treatment of pain and their use
ATA18093A (en) HYPERTHERMAL TREATMENT CATHETER
ID28817A (en) USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT
DE59811703D1 (en) Medical or dental treatment chair
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism
ITFI920241A0 (en) USE OF MELATONIN IN THE THERAPY OF SYSTEMATIC SCLEROSIS, SARCOIDOSIS AND OTHERS
YU40098A (en) The use of olanzapine in preparation of medicine
KR950008161U (en) Personal poultice sauna
KR980000770U (en) Medical treatment device with desk
KR950003086U (en) Infrared Therapy for Medical Science

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119586

Country of ref document: FI

MA Patent expired